Spruce Biosciences, Inc.

SPRB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$53-$48-$46-$42
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$5$0$4
Change in WC-$9$10$1$2
Other Non-Cash$6-$0$3$0
Operating Cash Flow-$56-$33-$42-$36
Investing Activities
PP&E Inv.$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$12-$37-$79
Inv. Sales/Matur.$0$68$61$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$56$24-$79
Financing Activities
Debt Repay.-$2-$2$0$0
Stock Issued$0$54-$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$3-$0$0
Financing Cash Flow-$2$49-$0$1
Forex Effect$0$0$0$0
Net Chg. in Cash-$58$72-$18-$114
Supplemental Information
Beg. Cash$96$25$43$157
End Cash$39$96$25$43
Free Cash Flow-$56-$33-$42-$36
Spruce Biosciences, Inc. (SPRB) Financial Statements & Key Stats | AlphaPilot